Aminoglycoside antibiotic derivatives: Preparation and evaluation of toxicity on cochlea and vestibular tissues and antimicrobial activity

Aminoglycoside antibiotic derivatives such as neamine, methyl neobiosaminide B, 2-deoxystreptamine, tetra-azidoneamine, tetra-N-acetylneamine, tetra-N-carboxy-benzylneamine, tetra-N-carboxy-methylneamine and tetra-p-methoxy-benzyliminoneamine were prepared and evaluated as to their cochlear and vestibular toxicity. Methyl neobiosaminide B, the most promising derivative in the series showed selective, cochlea-dissociated vestibulotoxic activity and was considered to be a potential lead compound for the treatment of Ménière’s disease. Antimicrobial properties of the compounds, qualitatively evaluated against a group of pathogenic bacteria, indicated that neomycin B sulfate, neamine as a free base and methyl-neobiosaminide B dihydrochloride show a broader range of activity when compared to the other derivatives.

Neomycin derivatives such as neamine, methyl neobiosaminide B, 2-deoxystreptamine, tetra-azidoneamine, tetra-N-acetylneamine, tetra-N-carboxybenzylneamine, tetra-N-carboxymethylneamine and tetra-p-methoxybenzyliminoneamine were prepared and evaluated in cochlear and vestibular tissues and antibacterial screening. Methyl neobiosaminide B has shown the most selective vestibular activity suggesting its potential use in Ménière’s disease.Figure optionsDownload as PowerPoint slide